<DOC>
	<DOC>NCT01439139</DOC>
	<brief_summary>The aim of clinical study is to assess effectiveness of Bone UltraSonic Scanner (BUSS) versus densitometry (DXA) in osteoporosis detection.</brief_summary>
	<brief_title>Bone UltraSonic Scanner (BUSS): Validation Study</brief_title>
	<detailed_description>Study will conduct measurements in a group of postmenopausal women and use their DXA examination data as a control. BUSS data will be able to discriminate between postmenopausal women with osteoporosis compared with no osteoporosis defined by DXA measurements.</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases, Metabolic</mesh_term>
	<criteria>Postmenopausal Age 5090 years Any race or ethnicity DXA spine and hip exam within one year Open wounds or rashes on the testing area Active skin infection Recent tibia surgery Abnormal tibia anatomy Body Mass Index &gt; 34.9 kg/m2 Current or previous tibial fracture on side of testing Stroke or with total or partial paralysis with residual disability lasting more than 3 months Current or recent (within past 6 months) use of boneactive drugs: Bisphosphonates Calcitonin Estrogens or selective estrogen receptor modulator (SERM) Therapeutic doses of fluoride (&gt; 2mg/day) Teriparatide used currently or within past 3 months Drugs under research protocols, and Unstudied or unapproved drugs Presence of metabolic bone disease</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>ultrasound</keyword>
	<keyword>sonometer</keyword>
	<keyword>DXA</keyword>
</DOC>